Status
Conditions
Treatments
About
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).
Full description
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).
Clinical, patient reported and imaging data that are assessed in clinical routine will be prospectively collected. All patients that are treated for BPE / BPH-LUTS at our institution will be included if they provide written informed consent.
This registry enables us to compare novel treatment option (e.g. prostatic artery embolization; PAE) to established interventions (e.g., TURP, HoLEP, open prostatectomy, ThuLEP, Thulium laser vaporization, TUIP) regarding safety and efficacy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
-Cognitive impairment not allowing Informed Consent or adequate data assessment.
500 participants in 3 patient groups
Loading...
Central trial contact
Dominik Abt, MD; Gautier Müllhaupt, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal